SCHEMBL7097948

SCHEMBL7097948

N#CCc1cc(C(F)(F)F)cc(Cl)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MRGPRX4 Q96LA9 4/20 0.33
▸ PKM P14618 2/20 0.33
▸ PKLR P30613 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ CSNK2A1 P68400 1/20 0.33
▸ DDR1 Q08345 1/20 0.32
▸ GABRB3 P28472 5/20 0.32
▸ GABRA2 P47869 3/20 0.32
▸ GABRB2 P47870 3/20 0.32
▸ GABRP O00591 2/20 0.32
▸ GABRD O14764 2/20 0.32
▸ GABRA1 P14867 2/20 0.32
▸ GABRB1 P18505 2/20 0.32
▸ GABRG2 P18507 2/20 0.32
▸ GABRA5 P31644 2/20 0.32
▸ GABRA3 P34903 2/20 0.32
▸ GABRA4 P48169 2/20 0.32
▸ GABRE P78334 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18600038 0.81 GABRP (0.36) MRGPRX4ALDH1A1GAAHTTCSNK2A1
SCHEMBL12251140 0.80 PDE2A (0.38) MRGPRX4PKMALDH1A1GAAGABRB3
SCHEMBL17062134 0.78 PKM (0.38) MRGPRX4PKMPKLRALDH1A1GAA
SCHEMBL4961852 0.77 MRGPRX4 (0.47) MRGPRX4ALDH1A1HTTRXRARXRB
SCHEMBL30858773 0.77 MRGPRX4 (0.47) MRGPRX4ALDH1A1HTTRXRARXRB
SCHEMBL30858772 0.77 SLC6A4 (0.43) MRGPRX4ALDH1A1HTTL3MBTL1SMN1; SMN2
SCHEMBL29179953 0.77 SLC6A4 (0.43) MRGPRX4ALDH1A1HTTL3MBTL1SMN1; SMN2
SCHEMBL16771000 0.77 ALDH1A1 (0.38) MRGPRX4PKMPKLRALDH1A1GAA
SCHEMBL2925876 0.77 PDE2A (0.36) MRGPRX4PKMPKLRALDH1A1GAA
SCHEMBL147630 0.77 PKM (0.35) MRGPRX4PKMPKLRALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6528657-B2 For use in electroluminescence light emission element and can emit lights of various colors when an energy such as electric energy or electromagnetic energy is applied thereto TAIHO INDUSTRIES CO., LTD. (JP) 2003-03-04 — — US disclosed
US-20030023099-A1 Novel fluorescent carbazole derivative HIROSE ENGINEERING CO., LTD. (JP) 2003-01-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030023099-A1 Novel fluorescent carbazole derivative CBR3, AANAT, SIRT3 MRGPRX4 3232/4885PKM 3691/4885PKLR 4386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback